Send us Feedback

Arca Biopharma Inc (ABIO)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 30-SEP
2007		 31-DEC
2007		 31-MAR
2008		 30-JUN
2008		 30-SEP
2008
Cash & Equivalents 45.1M 32.1M 38.0M 42.7M 35.2M
Short Term Investments 66.1M 65.5M 43.2M 27.3M 24.0M
Accounts Receivable 430K 588K 834K 1.08M 835K
Inventories 0 0 0 0 0
Pre-paid Expenses 0 0 0 0 0
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 2.46M 1.83M 1.46M 849K 950K
Total Current Assets 114M 100.0M 83.5M 72.0M 60.9M
Property, Plant & Equipment 9.46M 8.91M 8.45M 7.94M 7.38M
Goodwill & Intangibles 4.67M 4.67M 4.67M 0 0
Other Long-term Assets 7.13M 7.12M 7.11M 7.10M 7.10M
Total Long-Term Assets 21.3M 20.7M 20.2M 15.0M 14.5M
Accounts Payable 2.22M 2.76M 2.39M 2.59M 2.64M
Accrued Expenses 0 0 0 0 0
Short Term Debt 229K 0 0 0 0
Long Term Debt 0 0 0 0 0
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 36.6M 34.8M 19.9M 18.1M 16.3M
Minority Interest 0 0 0 0 0
Total Liabilities 58.0M 53.0M 52.1M 34.7M 30.7M
Preferred Stock 0 0 0 0 0
Common Par 53.0K 53.0K 53.0K 53.0K 53.0K
Additional Paid-In Capital 536M 538M 540M 541M 542M
Retained Earnings -459M -471M -489M -489M -498M
Treasury Stock 0 0 0 0 0
Other Equity 5000 49.0K 88.0K 12.0K -90.0K
Total Shareholder's Equity 77.4M 67.7M 51.6M 52.3M 44.7M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki